The FY2025 (Dec) proxy of Biohaven names 21 peer companies for pay. Pay versus performance data of Biohaven for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| Cogent Biosciences | ||
| BridgeBio Pharma | ||
| ImmunityBio | ||
| Immunovant | ||
| Xenon Pharmaceuticals | ||
| Vir Biotechnology | ||
| Vera Therapeutics | ||
| Arvinas | ||
| Denali Therapeutics | ||
| Anaptys Bio | Not disclosed | Not disclosed |
| Apellis Pharmaceuticals | Not disclosed | Not disclosed |
| Arrowhead Pharmaceuticals | Not disclosed | Not disclosed |
| Axsome Therapeutics | Not disclosed | Not disclosed |
| Crinetics Pharmaceuticals | Not disclosed | Not disclosed |
| Intra-Cellular Therapies | Not disclosed | Not disclosed |
| Iovance Biotherapeutics | Not disclosed | Not disclosed |
| Longboard Pharmaceuticals | Not disclosed | Not disclosed |
| Neumora Therapeutics | Not disclosed | Not disclosed |
| Rhythm Pharmaceuticals | Not disclosed | Not disclosed |
| Sage Therapeutics | Not disclosed | Not disclosed |
| Xencor | Not disclosed | Not disclosed |
21 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.